Kompetansesenter MR Spektroskopi - Kontaktutvalget
- Prosjektnummer
- 46011600-10
- Ansvarlig person
- Ingrid S. Gribbestad
- Institusjon
- St. Olavs Hospital
- Prosjektkategori
- Strukturelt tiltak
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score.
NMR Biomed 2013 May;26(5):600-6. Epub 2012 des 27
PMID: 23280546
Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
Neurosurgery 2013 Feb;72(2):186-95; discussion 195.
PMID: 23147779
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts.
Mol Oncol 2013 Feb;7(1):130-42. Epub 2012 okt 23
PMID: 23142657
Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Invest Radiol 2012 Nov;47(11):624-33.
PMID: 23011187
Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study.
PLoS One 2012;7(7):e42330. Epub 2012 jul 30
PMID: 22860113
Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers.
NMR Biomed 2012 Nov;25(11):1271-9. Epub 2012 mar 8
PMID: 22407957
Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
NMR Biomed 2012 Sep;25(9):1033-42. Epub 2012 jan 26
PMID: 22279038
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.
BMC Cancer 2012;12():39. Epub 2012 jan 25
PMID: 22277092
Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples.
Clin Cancer Res 2012 Jun;18(12):3261-9. Epub 2012 apr 17
PMID: 22510345
Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
J Neurochem 2012 Nov;123(4):532-41. Epub 2012 okt 1
PMID: 22943908
Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice.
Neurochem Int 2012 Sep;61(4):444-54. Epub 2012 jun 16
PMID: 22709675
Direct measurement of backflux between oxaloacetate and fumarate following pyruvate carboxylation.
Glia 2012 Jan;60(1):147-58. Epub 2011 nov 3
PMID: 22052553
Quantitative importance of the pentose phosphate pathway determined by incorporation of 13C from [2-13C]- and [3-13C]glucose into TCA cycle intermediates and neurotransmitter amino acids in functionally intact neurons.
J Cereb Blood Flow Metab 2012 Sep;32(9):1788-99. Epub 2012 jun 20
PMID: 22714050
Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice.
Neurochem Int 2012 Jul;61(1):100-7. Epub 2012 apr 23
PMID: 22549035
In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
J Magn Reson Imaging 2012 May;35(5):1098-107. Epub 2011 des 14
PMID: 22170753
Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
J Magn Reson Imaging 2011 Nov;34(5):1099-109. Epub 2011 aug 23
PMID: 22002757
In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
MAGMA 2011 Dec;24(6):347-57. Epub 2011 sep 10
PMID: 21909791
MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.
NMR Biomed 2011 Jul;24(6):673-90.
PMID: 21793073
Monitoring neoadjuvant chemotherapy in breast cancer patients: Improved MR assessment at 3 T?
J Magn Reson Imaging 2011 Jul. Epub 2011 jul 14
PMID: 21761463
Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.
Mol Oncol 2011 Jun;5(3):224-41. Epub 2011 apr 23
PMID: 21536506
(13) C High-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns.
NMR Biomed 2011 Dec;24(10):1243-52. Epub 2011 apr 4
PMID: 21462378
Brain [U-13 C]glucose metabolism in mice with decreased a-ketoglutarate dehydrogenase complex activity.
J Neurosci Res 2011 Dec;89(12):1997-2007. Epub 2011 mar 3
PMID: 21374701
Altered 13C glucose metabolism in the cortico-striato-thalamo-cortical loop in the MK-801 rat model of schizophrenia.
J Cereb Blood Flow Metab 2011 Mar;31(3):976-85. Epub 2010 nov 17
PMID: 21081956
Knockout of GAD65 has major impact on synaptic GABA synthesized from astrocyte-derived glutamine.
J Cereb Blood Flow Metab 2011 Feb;31(2):494-503. Epub 2010 jul 28
PMID: 20664610
Tricarboxylic acid cycle activity measured by 13C magnetic resonance spectroscopy in rats subjected to the kaolin model of obstructed hydrocephalus.
Neurochem Res 2011 Oct;36(10):1801-8. Epub 2011 mai 21
PMID: 21603937
ß-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
Neurochem Int 2011 Aug;59(2):309-18. Epub 2011 jun 13
PMID: 21684314
Reduced astrocytic contribution to the turnover of glutamate, glutamine, and GABA characterizes the latent phase in the kainate model of temporal lobe epilepsy.
J Cereb Blood Flow Metab 2011 Aug;31(8):1675-86. Epub 2011 apr 27
PMID: 21522161
A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy.
Prostate 2011 Apr;71(5):461-9. Epub 2010 sep 21
PMID: 20860008
HR MAS MR spectroscopy in metabolic characterization of cancer.
Curr Top Med Chem 2011;11(1):2-26.
PMID: 20809888
Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation.
Cancer Res 2010 Sep;70(17):6692-6. Epub 2010 aug 10
PMID: 20699363
Triple-negative breast cancer: present challenges and new perspectives.
Mol Oncol 2010 Jun;4(3):209-29. Epub 2010 apr 24
PMID: 20537966
Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
NMR Biomed 2010 May;23(4):424-31. Epub 2010 jan 25
PMID: 20101607
Short echo time 1H MRSI of the human brain at 3T with adiabatic slice-selective refocusing pulses; reproducibility and variance in a dual center setting.
J Magn Reson Imaging 2010 Jan;31(1):61-70.
PMID: 20027568
Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis.
J Proteome Res 2010 Jul;9(7):3664-70.
PMID: 20507057
Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene Expression.
Transl Oncol 2010;3(4):252-63. Epub 2010 aug 1
PMID: 20689767
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
BMC Cancer 2010;10():433. Epub 2010 aug 17
PMID: 20716336
Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
NMR Biomed 2010 Jan;23(1):56-65.
PMID: 19650073
Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.
J Proteome Res 2010 Feb;9(2):972-9.
PMID: 19994911
Merging transcriptomics and metabolomics--advances in breast cancer profiling.
BMC Cancer 2010;10():628. Epub 2010 nov 16
PMID: 21080935
Alignment of high resolution magic angle spinning magnetic resonance spectra using warping methods.
Anal Chim Acta 2010 Dec;683(1):1-11. Epub 2010 sep 24
PMID: 21094376
Pyruvate carboxylation in different model systems studied by (13)C MRS.
Neurochem Res 2010 Dec;35(12):1916-21. Epub 2010 sep 15
PMID: 20842423
Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
J Magn Reson Imaging 2009 Jun;29(6):1300-7.
PMID: 19472387
Combining clinical assessment scores and in vivo MR spectroscopy neurometabolites in very low birth weight adolescents.
Artif Intell Med 2009 Oct;47(2):135-46. Epub 2009 mai 2
PMID: 19411169
Availability of neurotransmitter glutamate is diminished when beta-hydroxybutyrate replaces glucose in cultured neurons.
J Neurochem 2009 Jul;110(1):80-91. Epub 2009 mai 18
PMID: 19457063
Mild reduction in the activity of the alpha-ketoglutarate dehydrogenase complex elevates GABA shunt and glycolysis.
J Neurochem 2009 May;109 Suppl 1():214-21.
PMID: 19393030
Gray matter metabolism in acute and chronic hydrocephalus.
Neuroscience 2009 Mar;159(2):570-7. Epub 2009 jan 10
PMID: 19171182
Quantification of amounts and (13)C content of metabolites in brain tissue using high- resolution magic angle spinning (13)C NMR spectroscopy.
NMR Biomed 2009 Apr;22(3):266-71.
PMID: 19012315
Neuronal glucose but not lactate utilization is positively correlated with NMDA-induced neurotransmission and fluctuations in cytosolic Ca2+ levels.
J Neurochem 2009 May;109 Suppl 1():87-93.
PMID: 19393013
Acute changes in intermediary metabolism in cerebellum and contralateral hemisphere following middle cerebral artery occlusion in rat.
J Neurochem 2009 May;109 Suppl 1():174-81.
PMID: 19393025
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.
Mol Cancer 2008;7():33. Epub 2008 apr 25
PMID: 18439252
Characterization of brain metastases using high-resolution magic angle spinning MRS.
NMR Biomed 2008 Feb;21(2):175-85.
PMID: 17542042
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.
Magn Reson Med 2008 Sep;60(3):510-6.
PMID: 18727052
Distinct changes in neuronal and astrocytic amino acid neurotransmitter metabolism in mice with reduced numbers of synaptic vesicles.
J Neurochem 2008 Apr. Epub 2008 apr 9
PMID: 18346203
Brain metabolism in adult chronic hydrocephalus.
J Neurochem 2008 Aug;106(4):1515-24. Epub 2008 apr 14
PMID: 18419769
Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy.
Neurochem Res 2008 Feb;33(2):257-66. Epub 2007 aug 21
PMID: 17710539
The effect of single and repeated UVB radiation on rabbit lens.
Graefes Arch Clin Exp Ophthalmol 2008 Apr;246(4):551-8. Epub 2008 jan 12
PMID: 18193260
Bertilsson, Helena; Giskeødegård, Guro F.; Selnæs, Kirsten Margrete; Wright, A; Bathen, Tone Frost; Viset, Trond; Halgunset, Jo
Vitenskapelige forhandlinger / De norske kirurgiske foreninger 2012
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.
Kongsvold møte; 2012-08-29 - 2012-08-30
Metabolic response to glycerophosphocholine phosphodiesterase GDPD5 silencing in human breast cancer cells.
Metabomeeting 2012; 2012-09-25 - 2012-09-27
Metabolic response to glycerophosphocholine phosphodiesterase GDPD5 silencing in human breast cancer cells.
Personalized cancer care 2012; 2012-09-07 - 2012-09-09
siRNA-mediated silencing of the glycerophosphocholine phosphodiesterase GDPD5 in breast cancer cells.
ISMRM annual scientific meeting 2012; 2012-05-05 - 2012-05-11, Regional forskningskonferanse HMN 2012; 2012-06-05 - 2012-06-06, and Opening of MR Core Facility; 2012-10-23 - 2012-10-23
In vivo 31P characterization of breast cancer.
OSBREAC Workshop on Breast cancer; 2012-08-29 - 2012-08-31 and Opening of MR Core Facility; 2012-10-23 - 2012-10-23
31P MRS of basal-like and luminal-like breast tumor xenografts in vivo and in vitro.
4th National PhD Conference in Medical Imaging 2012; 2012-11-28 - 2012-11-29
Laktat og glycin - mulige metabolske markører for brystkreftprognose, analysert med MR spektroskopi (MRS)
Høstmøtet Norsk Kirurgisk Forening; 2012-10-22 - 2012-10-26
CLASSIFICATION OF TUMOR AND NON-INVOLVED BREAST TISSUE USING HR-MAS MR SPECTROSCOPY.
XIII Chemometrics in Analytical Chemistry; 2012-06-25 - 2012-06-29
Metabolic changes in citrate and spermine concentrations can predict prostate cancer agressiveness
EMUC; 2012-11-16 - 2012-11-18, ESMRMB; 2012-10-04 - 2012-10-06, and ESUR; 2012-10-25 - 2012-10-27
Metabolic changes in indolent and aggressive prostate cancer - correlations with the Gleason grading system.
Regionale forskningskonferanse; 2012-06-05 - 2012-06-06 and Metabomeeting; 2012-09-25 - 2012-09-27
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
Opening of MR Core Facility, DMF, NTNU; 2012-10-23 - 2012-10-23, and Personalized cancer care; 2012-09-07 - 2012-09-09
Metabolic characterization of triple negative breast cancers. Personalized cancer care;
Personalized cancer care; 2012-09-07 - 2012-09-09
Metabolic characterization of triple negative breast cancers.
ESMRMB; 2012-10-04 - 2012-10-06
HR MAS MRS studies of breast cancer biopsies for defining clinically relevant sub-groups.
National PhD Conference in Medical Imaging; 2012-11-28 - 2012-11-29
Moestue, Siver Andreas; Flatabø, Silje; Huuse, Else Marie; Lindholm, Evita Maria; Engebråten, Olav; Akslen, Lars A.; Mælandsmo,
EACR 2012; 2012-07-07 - 2012-07-12
Citrate as a biomarker in discriminating aggressive from indolent form of prostate cancer by MR metabolomics-correlation with th
National PHD Conference in Medical Imaging; 2012-11-28 - 2012-11-29
Use of diffusion-derived metrics in assessing various tumor characteristics in immune deficient mice with prostate cancer.
The 4th National PhD Conference in Medical Imaging; 2012-11-28 - 2012-11-29
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer – Investigation of correlation with Gleason score
20th Meeting of the EAU section of Urological Research (ESUR); 2012-10-25 - 2012-10-27, EMUC 2012; 2012-11-16 - 2012-11-18, Instituttseminar ISB; 2012-10-19 - 2012-10-19, and Regionale forskningskonferansen; 2012-06-05 - 2012-06-06
Differentiating diffuse WHO grade II and IV Astrocytomas using ex vivo MR Spectroscopy.
ESMRMB annual scientific meeting; 2012-10-04 - 2012-10-06
Wright, A. J.; Kobus, T; Selnæs, Kirsten Margrete; Gribbestad, Ingrid S; Weiland, E; Scheenen, Tom WJ; Heerschap, Arend.
Benelux chapter of ISMRM; 2012-01-10 - 2012-01-10, and ISMRM annual meeting; 2012-05-05 - 2012-05-11
Quantitative 1H HR-MAS using LC Model shows glutamate, choline, glycerophosphocholine, and glucose as biomarkers of prostate can
ISMRM 2012; 2012-05-05 - 2012-05-11
In vivo 13C MR spectroscopy and MR imaging in rats with kaolin-induced hydocephalus
European Journal of Neurology 2011; Volum 18, s 567-567
In vivo proton magnetic resonance spectroscopy in a transgenic rat model of Alzheimer's Disease
Int. Society for Neurochemistry&European Society for Neurochemistry 23rd Biennal Meeting; 2011
Altered brain glutamate levels in a rat model of Alzheimer's Disease
Healthy Brain Conference; 2011
Fresh prostate tissue procurements suitable for integrative genomic and metabolic profiling.
European Urology Supplements; 2011 Volume: 10 Issue: 2 Pages: 115-116
Fresh prostate tissue harvesting for integrative genomic and metabolic profiling.
European Association of Urology; 2011
Effects of targeting the glycerophosphocholine phosphodiesterase GDPD5 in breast cancer models.
Int. society of MR in Medicine (ISMRM) 2011; Montreal, Canada
GDPD5 expression correlates with choline metabolite profiles in human breast cancer.
FUGE workshop; 2011, Haukeland
In vivo 3D 31P MR spectroscopic imaging of human brain tumors growing orthotopic in the mouse.
European Society of MR in Medicine and Biology (ESMRMB); 2011
31P MRS of basal- and luminal-like breast tumor xenografts in vivo and in vitro.
ESMRMB 2011
Detection of MR metabolic biomarkers for breast cancer prognosis.
Metabomeeting; 2011
Revealing MR metabolic biomarkers for breast cancer prognosis.
ESMRMB; 2011
NTNU i verdenstoppen på MR
Adresseavisen 2011
Åpning av MR metabolomics lab
NRK Trøndelag (Radio), 20.01.2011
13C HR-MAS MR spektroskopi-analyser av brystkreftxenografter.
Regional Forskningskonferanse HMN-NTNU; 2011
Metabolic profiles of 33 different breast cancer xenograft models studied by high-resolution-magic angle spinning MR spectroscop
PhD-seminar NTNU
Metabolic profiles of three breast cancer subgroups studied with HR-MAS MRS.
ESMRMB 2011
Midt-Nytt 18.40
NRK Midt-Nytt (TV), 29.09.2011
Assessment of metabolic responses to PI3K inhibition in basal-like breast cancer xenografts using HR MAS MRS.
ESMRMB; 2011
Early vascular response to bevacizumab treatment measured by DCE-MRI in breast cancer xenografts.
Medical Imaging PhD seminar; 2011
Correlation Between In Vivo 1H MRS and Ex Vivo 1H HR MAS in Spatially Matched Regions in Prostate Cancer Patients.
ISMRM 2011
Spatially matched in vivo and ex vivo MR molecular profiling of prostate cancer.
ESMRMB; 2011
MR metabolomics i biomedisinsk forskning.
Helse, Medisin, Teknikk 2011 (2) s. 8-14
Low aerobic fitness is associated with altered levels of choline-containing metabolites in human serum.
ESMRMB 2011
The choline signatures of brain tumor subgroups.
ESMRMB 2011
MR determind metabolites may serve as prognostic factors in breast cancer.
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
A new harvesting method to provide high quality prostate cancer tissue suitable for 1H HR MAS MR spectroscopy and gene expressio
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
Silencing the glycerophosphocholine phosphodiesterase GDPD5 reduced breast tumor growth and modulated tumor choline phospholipid
International Society of Magnetic Resonance in Medicine, Workshop in California, 2010 (Oral presentation)
Predicting long-term breast cancer survival in patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
MI Lab day, NTNU; 2010-04-29
Predicting long-term survival for breast cancer patients by HR MAS metabolic profiling during neoadjuvant chemotherapy.
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (oral presentation)
Peak alignment of MR spectra.
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
Alignment of high resolution magic angle spinning MR spectroscopy data
12th International Conference on Chemometrics in Analytical Chemistry (abstract)
Functional and molecular MR for breast cancer characterization
European Association Cancer Research conference, Oslo (invited lecture)
How to perform HR MAS studies in tissue
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (invited lecture)
HR MAS MR spectroscopy of intact cancer tissue samples
Cambridge Research Institute Annual Symposium (Unanswered Questions in Tumour Monitoring), Cambridge UK (Invited talk)
HR MAS MRS of biopsy samples
Sahlgrenska University Hospital, Gøteborg (Invited lecture)
Molekylær og funksjonell MR
FUGE Workshop, NTNU (invitert foredrag)
MR av kreft – fra molekyl til pasient.
Fagdagene, Åpning av St. Olavs Hospital (invitert foredrag)
MR Cancer Group med i to av Jebsen-sentrene.
www.universitetsavisa.no 2010
MR metabolomics of Cancer Tissue
Kreftavdelingen, St. Olavs Hospital (internundervisning)
MRI- Functional and metabolic possibilities
NTNU Symposium: Man in extreme environment (invited talk)
MR monitoring of Breast Cancer Treatment
Kreftavdelingen, St. Olavs Hospital (internundervisning)
Prinsipper for metabolske studier in vivo og in vitro av brystkreft.
Ullevål Symposiet (invitert foredrag)
Samarbeidsprosjekt om brystkreft
FUGE Nyhetsbrev, Forskningsrådet, 2010 (intervju)
13C HR-MAS MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expressi
International Society of Magnetic Resonance in Medicine, Cancer Workshop California (oral presentation)
13C HR MAS MRS reveals differences in the glucose metabolism between two breast cancer xenograft models with different gene expr
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
13C HR-MAS MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expressi
Brystkreft Workshop, Kongsvold, august 2010 (foredrag)
Dynamic contrast-enhanced magnetic resonance imaging reveals differences in xenografts with luminal like and basal like gene exp
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like bre
Brystkreft Workshop, Kongsvold, august 2010 (foredrag)
Diffusion weighted and dynamic contrast enhanced MRI in evaluation of treatment effects during neoadjuvant chemotherapy
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
DW-MRI in monitoring early response to bevacizumab therapy in breast cancer xenografts
International Society of Magnetic Resonance in Medicine, Cancer Workshop California (poster)
Choline metabolism in basal-like and luminal-like breast cancer xenografts respond differently to doxorubicin and bevacizumab tr
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
Metabolic changes in luminal-like orthotopic breast cancer xenografts following estrogen supplement withdrawal
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
Evaluating the prognostic value of breast cancer biomarker candidates identified by HR-MAS MRS tissue analysis.
International Society of Magnetic Resonance in Medicine, Cancer Workshop California (oral presentation)
MR spectroscopy of breast cancer patients for prediction of treatment response – combining in vivo and ex vivo analysis.
Proc. International Society of Magnetic Resonance in Medicine, Stockholm May 2010 (abstract)
MR spectroscopy of breast cancer patients for prediction of treatment response – combining in vivo and ex vivo analysis.
11th National Norwegian NMR Meeting; 2010
Metabolomics - et spennende verktøy i medisinsk og biologisk forskning.
NBS-nytt 2009; Volum 1. s. 10-15
High-resolution MAS MRS of breast cancer biopsies - different approaches.
European Radiology 2009, 19. Suppl, 822-826
MR metabolomics – a tool in detection of biomarkers for response to neoadjuvant chemotherapy in local advanced breast cancer?
ESMRMB 2009 ; Turkey
Choline metabolites as biomarkers for predicting response to neoadjuvant chemotherapy in local advanced breast cancer patients.
ISMRM Conference proceedings, Hawaii; 2009
Short echo time 1H MRSI of the human brain at 3T with adiabatic slice-selective refocusing pulses; reproducibility and variance
J Magn Reson Imaging. E-publ 2009 (Pubmed)
MR metabolomics – a tool in detection of biomarkers for response to neoadjuvant chemotherapy in local advanced breast cancer?
ESMRMB 2009
Classification and prediction of prognostic factors of breast cancer patients by MR metabolomics.
ISMRM; 2009
Monitoring cancer treatment using gene expression, MRI and MRS.
FUGE MIC Workshop, 2009
MR determined phenotype of breast cancer in prediction of lymphatic spread, grade and hormone status.
Mammary gland biology: Basic and clinical aspects; 2009
MRI/MRS in neoadjuvant chemotherapy, 1.5 and/or 3T?.
Fifth International Congress of MR Mammography; 2009
High-resolution MAS MRS of breast cancer biopsies - different approaches.
Fifth International Congress on MR Mammography; 2009
HR MAS 13C MRS characterization of two breast cancer xenograft models.
ESMRMB; 2009
In vivo and ex vivo choline metabolite profiles as biomarkers for treatment response in locally advanced breast cancer.
ISMRM; 2009
Multiparametric MRI/MRS and gene expression profiling for monitoring docetaxel effects in MCF7 xenografts.
ISMRM; 2009
Multiparametric MR exam (MRI/MRSI/DWI/DCE) at 3T without endorectal coil for prostate cancer detection: correlation to histopath
ESMRMB 2009
Local staging of prostate caner in a routine clinical setting using a 3T MR exam without endorectal coil; a correlation with his
European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) Conference proceedings; 2009
Tissue metabolic concentrations investigated with respect to prognosis for breast cancer patients.
ISMRM 2009
High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer.
Progress in nuclear magnetic resonance spectroscopy 2009 ;Volum 54.(3-4) s. 239-254
Subclassification of brain tumors based on ex vivo MRS metabolic profiles.
ISMRM 2009
Characterization and evaluation of metabolic biomarkers for human colon adenocarcinomas by 1H HR MAS.
International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting, Conference Proceeding; 2009
Omega-3 fatty acids suppress growth of SW620 human colon cancer xenografts in nude mice.
Anticancer Research 28:3717-3724, 2008
High resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer.
Accepted Progress in NMR spectroscopy, August 2008
Molecular and functional characterization of breast cancer through a combination of MR imaging, transcriptomics and metabolomics
- Disputert:
- januar 2012
- Hovedveileder:
- Ingrid S. Gribbestad
MR metabolic characterization of locally advanced breast cancer
- Disputert:
- mars 2012
- Hovedveileder:
- Ingrid S. Gribbestad
MR imaging and spectroscopy in prostate and colon cancer diagnostics
- Disputert:
- september 2012
- Hovedveileder:
- Ingrid S. Gribbestad
Characterization of breast cancer using MR metabolomics and gene expression analysis
- Disputert:
- oktober 2012
- Hovedveileder:
- Ingrid S. Gribbestad
Transcriptomics and metabolomics of breast cancer to improve the understanding of disease mechanisms and treatment response
- Disputert:
- mai 2012
- Hovedveileder:
- Therese Sørlie (UiO) og Ingrid S. Gribbestad
Prostate Cancer - Translation Research
- Disputert:
- september 2012
- Hovedveileder:
- Jostein Halgunset
Evaluation of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer based on MR Methodology
- Disputert:
- juni 2011
- Hovedveileder:
- Tone F. Bathen
Identification and Characterization of prognostic factors in breast cancer using MR metabolomics
- Disputert:
- desember 2011
- Hovedveileder:
- Tone F. Bathen
Evaluation of treatment effects in cancer by MR imaging and spectroscopy
- Disputert:
- mars 2010
- Hovedveileder:
- Ingrid S. Gribbestad
MR evaluation of Breast Cancer Patients with a Poos Prognosis
- Disputert:
- oktober 2010
- Hovedveileder:
- Steinar Lundgren
Assessment of tumor microenvironment and treatment effects un human breast cancer xenografts using MR imaging and spectroscopy
- Disputert:
- november 2010
- Hovedveileder:
- Ingrid S. Gribbestad
13C NMRS of animal models of schizophrenia
- Disputert:
- oktober 2009
- Hovedveileder:
- Ursula Sonnewald
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU